Join the 2017 Research Drive to Help #CureAtaxia The Annual Ataxia Research Drive began on October 15 with the challenge to raise $400,000 by December 15 to fund the finest Read More…
2017 Research Drive Kicks Off

Join the 2017 Research Drive to Help #CureAtaxia The Annual Ataxia Research Drive began on October 15 with the challenge to raise $400,000 by December 15 to fund the finest Read More…
BIOHAVEN OPTIMISTIC FOR NEXT PHASE OF TRIAL DESPITE DISAPPOINTING TOPLINE DATA As NAF previously reported, BioHaven Pharmaceutical Holding Company Ltd. recently completed its 8-week trial of dosing for its drug compound Read More…